Phar­ma-backed Mis­sion Ther­a­peu­tics stops pre­clin­i­cal op­er­a­tions, fo­cus­es on two clin­i­cal as­sets

Clin­i­cal-stage biotech Mis­sion Ther­a­peu­tics is clos­ing its pre­clin­i­cal lab­o­ra­to­ry op­er­a­tions in Cam­bridge, UK, a spokesper­son con­firmed to End­points News.

The biotech will fo­cus on its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER